Keloids--clinical diagnosis, pathogenesis, and treatment options

J Dtsch Dermatol Ges. 2004 Nov;2(11):905-13. doi: 10.1046/j.1439-0353.2004.04077.x.

Abstract

Keloids are defined as excessive scar tissue formation extending beyond the area of the original skin injury and occurring in predisposed individuals. They are considered to be a result of abnormal wound healing. The pathogenetic mechanisms that cause keloids remain unknown. Experiments with cells derived from keloid tissue revealed a number of abnormalities in cellular functions, such as in proliferation, apoptosis, or expression of growth factors and extracellular matrix proteins. Furthermore, several studies have reported altered keratinocyte-fibroblast interactions in keloids. Despite the diverse pathological changes in cellular functions and expression profiles of cells derived from keloid tissue, recent genetic studies have provided evidence that single genes may act as major regulators of keloid formation. We provide an overview of the pathogenetic mechanisms of keloid formation in the context of their clinical characteristics and current therapeutic approaches.

Publication types

  • Review

MeSH terms

  • Dermatologic Agents / therapeutic use*
  • Humans
  • Keloid / diagnosis
  • Keloid / physiopathology*
  • Keloid / therapy*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'

Substances

  • Dermatologic Agents